Answers are grounded in this paper and cite their sources.
Neuroendocrine prostate cancer is complex, comprising a wide spectrum of phenotypes, which has led to very different entities being inappropriately lumped together or assumed to behave like more common entities. Elucidating subtle differences is critical for treatment decision making, as this commentary describes.
No takes yet. Share an insight, caveat, or question.
Serritella et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: